AMNEAL PHARMACEUTICALS INC (AMRX)
US03168L1052 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -48.72M | -254.79M | 20.17M | 68.60M | -603.60M | |||
| Depreciation Amortization | 229.40M | 240.18M | 233.41M | 235.40M | 207.20M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | 371.70M | |||
| Change In Working Capital | -47.19M | -59.95M | -133.59M | -61.30M | -120.20M | |||
| Interest Paid | 192.81M | 142.72M | 121.75M | 130.20M | 158.60M | |||
| Taxes Paid | -2.50M | -12.65M | -15.56M | 100.10M | 10.30M | |||
| Other non cash items | 212.09M | 139.66M | 121.84M | 136.40M | 146.50M | |||
| OPERATING CASH FLOW | 345.58M | 65.10M | 241.82M | 379.00M | 1.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -69.19M | -90.59M | -52.64M | -66.20M | -97.40M | |||
| Other Investing Activity | 0.00 | -83.71M | -141.54M | -251.40M | 77.90M | |||
| INVESTING CASH FLOW | -69.19M | -174.31M | -194.18M | -317.50M | -19.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 22.65M | -38.27M | -79.18M | 143.00M | -29.30M | |||
| Stock Issued/Repurchased | 451.00K | 662.00K | 853.00K | 300.00K | 1.40M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Financing Activity | -235.68M | -69.01M | -59.80M | -11.50M | -18.00M | |||
| FINANCING CASH FLOW | -212.57M | -106.62M | -138.12M | 131.80M | -45.80M | |||
| Exchange Rate Effect | 65.00K | -5.68M | 102.00K | 1.00M | -2.20M | |||
| CHANGE IN CASH | 63.88M | -221.51M | -90.38M | 194.30M | -65.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 345.58M | 65.10M | 241.82M | 379.00M | 1.70M | |||
| Capital Expenditure | -69.19M | -90.59M | -52.64M | -66.20M | -97.40M | |||
| FREE CASH FLOW | 276.39M | -25.50M | 189.18M | 312.80M | -95.70M | |||
All data in USD